Vimarsana
Biggest News Aggregation in the World

Page 37 - Tak News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tak. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tak Today - Breaking & Trending Today

Takeda Pharmaceutical Company Limited (NYSE:TAK) Shares Sold by Twin Tree Management LP - Vimarsana News

Takeda Pharmaceutical Company Limited (NYSE:TAK) Shares Sold by Twin Tree Management LP

Twin Tree Management LP lessened its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK – Free Report) by 91.1% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 4,553 shares of the company’s stock after selling 46,476 shares during the quarter. Twin Tree […]

Hyundai Ioniq 5 ASEAN Tour: 5 EVs, 5 countries in 11 days - Vimarsana News

Hyundai Ioniq 5 ASEAN Tour: 5 EVs, 5 countries in 11 days

Hyundai has kicked off its Ioniq 5 ASEAN Tour from Singapore to Vietnam to showcase its EV's long-distance capabilities. It will cover 5 countries in 11 days.

Takeda Gets FDA Approval For Blood-Clotting Disorder Treatment - Vimarsana News

Takeda Gets FDA Approval For Blood-Clotting Disorder Treatment

By Ben Glickman Takeda's treatment for a rare blood clotting disorder received approval from the U.S. Food and Drug Administration. The FDA said Thursday it...

Nigerian Defense Delegation Examines First T129 ATAK Helicopter in Turkey - Vimarsana News

Nigerian Defense Delegation Examines First T129 ATAK Helicopter in Turkey

Nigeria has 6 T129s on order

Oppenheimer Asset Management Inc. Decreases Stock Position in Takeda Pharmaceutical Company Limited (NYSE:TAK) - Vimarsana News

Oppenheimer Asset Management Inc. Decreases Stock Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)

Oppenheimer Asset Management Inc. cut its stake in Takeda Pharmaceutical Company Limited (NYSE:TAK – Free Report) by 1.6% in the second quarter, HoldingsChannel reports. The firm owned 249,760 shares of the company’s stock after selling 4,120 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Takeda Pharmaceutical were worth $3,924,000 as of its most […]